CC BY-NC-ND 4.0 · Endosc Int Open 2020; 08(12): E1725-E1731
DOI: 10.1055/a-1266-3308
Original article

Incidental detection of colorectal lesions on 18F-FDG-PET/CT is associated with high proportion of malignancy: A study in 549 patients

Sabrina Just Kousgaard
1   Department of Gastrointestinal Surgery and Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark
3   Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
,
Michael Gade
2   Department of Nuclear Medicine, Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark
,
Lars Jelstrup Petersen
2   Department of Nuclear Medicine, Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark
3   Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
,
Ole Thorlacius-Ussing
1   Department of Gastrointestinal Surgery and Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark
3   Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
› Author Affiliations

Abstract

Background and study aims Further diagnostics of incidental colorectal lesions on 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is questionable. Therefore, we aimed to evaluate the clinical importance of incidentally detected colorectal lesions on FDG-PET/CT.

Patients and methods In the North Denmark Region, a retrospective study was performed among 19,987 patients who had an FDG-PET/CT from January 2006 to December 2015. Among these patients, we identified patients with a colonoscopy within 12 months from the PET/CT scan and a description of incidental colorectal PET-avid lesions on the PET/CT. PET findings were compared with colonoscopy-detected lesions and eventually histopathology.

Results Incidental PET-avid lesions were observed in 549 patients. Colonoscopy revealed lesions in 457 (83 %), among whom 338 patients had a final histopathological diagnosis. Malignant and premalignant lesions were found in 297 patients (54 % among patients with a PET-avid lesion). The lesions were cancer in 76 patients and adenoma in 221 patients of whom 30 had high-grade and 191 low-grade adenomas. The findings changed patient management in 166 cases (30 % of all patients with a PET-avid lesion). A colonoscopy-based surveillance program was initiated for 80 % of patients with high-grade adenoma. No patients with PET-avid lesions but normal colonoscopy developed colorectal cancer during 3 years of observation (median observation time 7 years).

Conclusions Incidental colorectal FDG uptake was infrequently observed, but when present, it was associated with a high rate of malignant or premalignant lesions. Our results indicate that patients with incidental colorectal FDG uptake should be referred to diagnostic work-up including colonoscopy.



Publication History

Received: 28 February 2020

Accepted: 18 August 2020

Article published online:
17 November 2020

© 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 El-Galaly T, Villa D, Gormsen L. et al. FDG-PET/CT in the management of lymphomas: current status and future directions. J Intern Med 2018; 284: 358-376
  • 2 Divisi D, Barone M, Zaccagna G. et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in the management of solitary pulmonary nodule: a review. Ann Med 2017; 49: 626-635
  • 3 Perng P, Marcus C, Subramaniam R. (18)F-FDG-PET/CT and melanoma: staging, immune modulation and mutation-targeted therapy assessment, and prognosis. AJR Am J Roentgenol 2015; 205: 259-270
  • 4 Dinnes J, Bancos I, Di Ruffano LF. et al. Management of endocrine disease: Imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: A systematic review and meta-analysis. Eur J Endocrinol 2016; 175: 51-64
  • 5 Gedberg N, Karmisholt J, Gade M. et al. The frequency of focal thyroid incidental findings and risk of malignancy detected by 18F-Fluorodeoxyglucose positron emission tomography in an iodine deficient population. Diagnostics (Basel) 2018; 8 pii: E46
  • 6 Uppal A, White M, Nagar S. et al. Benign and malignant thyroid incidentalomas are rare in routine clinical practice: a review of 97,908 imaging studies. Cancer Epidemiol Biomarkers Prev 2015; 24: 1327-1331
  • 7 Kousgaard S, Thorlacius-Ussing O. Incidental colorectal FDG uptake on PET/CT scan and lesions observed during subsequent colonoscopy: a systematic review. Tech Coloproctol 2017; 21: 521-529
  • 8 Pandit-Taskar N, Schöder H, Gonen M. et al. Clinical significance of unexplained abnormal focal FDG uptake in the abdomen during whole-body PET. Am J Roentgenol 2004; 183: 1143-1147
  • 9 Treglia G, Bertagna F, Sadeghi R. et al. Prevalence and risk of malignancy of focal incidental uptake detected by fluorine-18-fluorodeoxyglucose positron emission tomography in the parotid gland: a meta-analysis. Eur Arch Oto-Rhino-Laryngology 2014; 272: 3617-3626
  • 10 Na S-Y, Kim K-J, Han S. et al. Who should undergo a colonoscopy among patients with incidental colon uptake on PET-CT?. Scand J Gastroenterol 2015; 5521: 1-9
  • 11 Abdel-Nabi H, Doerr RJ, Lamonica DM. et al. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 1998; 206: 755-760
  • 12 Prabhakar HB, Sahani DV, Fischman AJ. et al. Bowel hot spots at PET-CT. Radiographics 2007; 27: 145-159
  • 13 Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology 1993; 189: 847-850
  • 14 Cook GJR, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: Potential for error in interpretation. Semin Nucl Med 1996; 26: 308-314
  • 15 Seivert M, Plomteux O, Colard A. et al. Endoscopic findings in case of incidental colonic uptake in PET-CT how to improve PET-CT specificity?. Acta Gastroenterol Belg 2014; 77: 413-417
  • 16 Farquharson AL, Chopra A, Ford A. et al. Incidental focal colonic lesions found on 18Fluorodeoxyglucose positron emission tomography/computed tomography scan: Further support for a national guideline on definitive management. Color Dis 2012; 14: 56-63
  • 17 Salazar AndíaG, Prieto SorianoA, Ortega CandilA. et al. Clinical relevance of incidental finding of focal uptakes in the colon during 18F-FDG-PET/CT studies in oncology patients without known colorectal carcinoma and evaluation of the impact on management. Rev española Med Nucl e imagen Mol 2012; 31: 15-21
  • 18 Lee JC, Hartnett GF, Hughes BGM. et al. The segmental distribution and clinical significance of colorectal fluorodeoxyglucose uptake incidentally detected on PET-CT. Nucl Med Commun 2009; 30: 333-337
  • 19 Strum W. Colorectal Adenomas. N Engl J Med 2016; 374: 1065-75
  • 20 Schlemper R, Riddell R, Kato Y. et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47: 251-255
  • 21 Colucci PM, Yale SH, Rall CJ. Colorectal Polyps. Clin Med Res 2003; 1: 261-262
  • 22 Strate LL, Modi R, Cohen E. et al. Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights. Am J Gastroenterol 2012; 107: 1486-1493
  • 23 Atkin WS, Saunders BP. Surveillance guidelines after removal of colorectal adenomatous polyps. Gut 2002; 51: 6-9
  • 24 Lin M, Koo JH, Abi-Hanna D. Management of patients following detection of unsuspected colon lesions by PET imaging. Clin Gastroenterol Hepatol 2011; 9: 1025-1032
  • 25 Valente M. Endoscopic and histopathological analysis of incidental focal colorectal 18 F-fluorodeoxyglucose uptake in PET/CT scan: Colonoscopic evaluation is warranted. Am J Surg 2018; 215: 379-381
  • 26 Shim JH, O. JH, Oh SIl. et al. Clinical significance of incidental colonic 18F-FDG Uptake on PET/CT images in patients with gastric adenocarcinoma. J Gastrointest Surg 2012; 16: 1847-1853
  • 27 Treglia G, Calcagni ML, Rufini V. et al. Clinical significance of incidental focal colorectal 18F-fluorodeoxyglucose uptake: Our experience and a review of the literature. Color Dis 2012; 14: 174-180
  • 28 Israel O, Yefremov N, Bar-Shalom R. et al. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med 2005; 46: 758-762
  • 29 Kei PL, Vikram R, Yeung HWD. et al. Incidental finding of focal FDG uptake in the bowel during PET/CT: CT features and correlation with histopathologic results. Am J Roentgenol 2010; 194: 401-406
  • 30 Garrido Durán C, Payeras Capó M, García Caparrós C. et al. Clinical-endoscopic relevance of incidental colorectal lesions detected by PET-CT. Rev Esp Enferm Dig 2018; 110: 434-439